Subsequently, Bcl-2 expression level was significantly decreased in both NPs-treated cancer cells by more than 15 folds and 5 folds compared to untreated healthy cancer cells and 5-FU-treated cancer cells, respectively (Fig. 6b). The gene discussed is BCL2; the disease is cancer.